Back to results
US 8,691,747 B2Granted
Method of treatment based on ATAD2 inhibitors
AssigneeGlaxo Group Limited
InventorsLaurens Kruidenier, Kevin Lee, David Francis Tough, David Matthew Wilson
Life of this patent
Estimating the term…
Abstract
A method of treating autoimmune and inflammatory diseases or conditions in a mammal, such as a human, which comprises the administration of a inhibitor of the bromodomain-containing protein: ATAD2.
Claims1
A method of treating autoimmune and inflammatory diseases and conditions in a human in need thereof, which comprises the administration of a therapeutically effective amount of an inhibitor of the bromodomain-containing protein ATAD2.
Dependencies are inferred from the claim text.